언어 선택

HLA-A*2402 & B2M & EBV BRLF1 (TYPVLEEMF)

HLA-A*2402 & B2M & EBV BRLF1 (TYPVLEEMF) 제품 목록

속성
Protein (1)
제품 라이브러리
온라인 (1)
종
Human (1)
태그
His Tag & Avi Tag (1)
마커
Unconjugated (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
HLF-H52E5	Human	HEK293	Unconjugated Human HLA-A*24:02&B2M&EBV BRLF1 (TYPVLEEMF) Complex Protein (Monomer, MALS verified)

총 수량1

HLA-A*2402 & B2M & EBV BRLF1 (TYPVLEEMF)분자 배경

This is a recombinant protein complex of HLA-A*24:02 presenting an immunodominant 9-mer peptide (TYPVLEEMF) derived from the Epstein-Barr virus (EBV) immediate-early transactivator BRLF1. HLA-A*24:02 is a common class I allele, and this peptide is a well-characterized target for CD8⁺ T cells in EBV-seropositive individuals, making the complex a valuable tool for studying antigen-specific T cell responses in viral immunity and immunotherapies.

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
CHM-2101	CDH17-CAR T; CHM-2101; CHM2101; CHM-2101 CAR-T cells	Phase 2 Clinical	University Of Pennsylvania	Stomach Neoplasms; Pancreatic Neoplasms; Neuroendocrine Tumors; Colorectal Neoplasms; Gastrointestinal Neoplasms	상세
BI-905711	BI-905711	Phase 1 Clinical	Boehringer Ingelheim Gmbh	Pancreatic Neoplasms; Cholangiocarcinoma; Gastrointestinal Neoplasms	상세
ARB-202	ARB-202	Phase 1 Clinical	Arbele Corp	Liver Neoplasms; Biliary Tract Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal adenocarcinoma; Gastrointestinal Neoplasms	상세